Enzyme inhibition, radical scavenging, and spectroscopic studies of vanadium(IV)–hydrazide complexes

Spectroscopic, enzyme-inhibition, and free-radical scavenging properties of a series of hydrazide ligands and their vanadium(IV) complexes have been investigated. Analytical and spectral data indicate the presence of a dimeric unit with two oxovanadium(IV) ions (VO2+) coordinated with two hydrazide ligands along with two water molecules. All complexes are stable in the solid state, but exhibit varying degrees of stability in solution. Binding of the coordinating solvent such as DMSO is indicated at the 6th position of vanadium in the dimeric unit followed by conversion to a monomeric intermediate species, [VOL(DMSO)3]1+ (L = hydrazide ligand). The free hydrazide ligands are inactive against snake venom phosphodiesterase I (SVPD), whereas oxovanadium(IV) complexes of these ligands show varying degrees of inhibition and are found to be non-competitive inhibitors. The superoxide and nitric oxide radical scavenging properties have been determined. Hydrazide ligands are inactive against these free radicals, whereas their V(IV) complexes show varying degrees of inhibition. Structure–activity relationship studies indicate that the electronic and/or steric factors that change the geometry of the complexes play an important role in their inhibitory potential against SVPD and free radicals.

[1]  R. Vijayaraghavan,et al.  New diketone based vanadium complexes as insulin mimetics. , 2008, European journal of medicinal chemistry.

[2]  S. S. Soares,et al.  Vanadium and cadmium in vivo effects in teleost cardiac muscle: metal accumulation and oxidative stress markers. , 2008, Comparative biochemistry and physiology. Toxicology & pharmacology : CBP.

[3]  Yan-fen Niu,et al.  Effects of bis(α-furancarboxylato)oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin-diabetic rats , 2007 .

[4]  C. Suresh,et al.  Rapid reduction and complexation of vanadium by 1-phenyl-3-methyl-4-toluoyl-5-pyrazolone: Spectroscopic characterization and structure modelling , 2007 .

[5]  Zheng Sun,et al.  Insulin-like model complexes: Synthesis, spectra characterization and crystal structure of two novel oxovanadium complexes with poly(pyrazolyl)borate ligands VO(HB(pz)3)(H2B(pz)2) and VO(B(pz)4)2 , 2007 .

[6]  S. Feng,et al.  Dinuclear oxovanadium(IV) compounds from designed amino acid derivatives , 2007 .

[7]  U. Ashiq,et al.  Chemistry, Urease Inhibition, and Phytotoxic Studies of Binuclear Vanadium(IV) Complexes , 2007, Chemistry & biodiversity.

[8]  Y. Adachi,et al.  Possible mode of action for insulinomimetic activity of vanadyl(IV) compounds in adipocytes. , 2006, Life sciences.

[9]  C. Supuran,et al.  Oxovanadium(IV) complexes of hydrazides: Potential antifungal agents , 2006, Journal of enzyme inhibition and medicinal chemistry.

[10]  M. Drew,et al.  Synthesis, structure and solution chemistry of mixed-ligand oxovanadium(IV) and oxovanadium(V) complexes incorporating tridentate ONO donor hydrazone ligands , 2005 .

[11]  I. Sóvágó,et al.  Vanadium(III) binding strengths of small biomolecules , 2005 .

[12]  Thomas J. Meyer,et al.  Comprehensive Coordination Chemistry II , 2004 .

[13]  S. Chakraborty,et al.  X-ray, spectral and biological (antimicrobial and superoxide dismutase) studies of oxalato bridged CuII-NiII and CuII-ZnII complexes with pentamethyldiethylenetriamine as capping ligand. , 2004, Journal of inorganic biochemistry.

[14]  D. Crans,et al.  The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds. , 2004, Chemical reviews.

[15]  T. Ueki,et al.  Vanadium-binding protein in a vanadium-rich ascidian Ascidia sydneiensissamea: CW and pulsed EPR studies. , 2003, Journal of the American Chemical Society.

[16]  B. Suresh,et al.  Antioxidant activity of the ethanolic extract of Striga orobanchioides. , 2003, Journal of ethnopharmacology.

[17]  D. Rehder,et al.  Thiofunctional vanadium complexes. , 2002, Inorganic chemistry.

[18]  Hiromu Sakurai,et al.  Antidiabetic vanadium(IV) and zinc(II) complexes , 2002 .

[19]  K. A. Salib,et al.  METAL COMPLEXES OF NOVEL SYMMETRICAL SCHIFF BASE LIGANDS , 2001 .

[20]  P. Schauerte,et al.  PC-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification. , 2001, The American journal of pathology.

[21]  A. Ceriello Oxidative stress and glycemic regulation. , 2000, Metabolism: clinical and experimental.

[22]  Y. Glories,et al.  Free radical scavenging effect of anthocyanins in red wines , 1999 .

[23]  J. McNeill,et al.  Vanadium Complexes as Insulin Mimetic Agents: Coordination Chemistry and in Vivo Studies of Oxovanadium(IV) and Dioxovanadate(V) Complexes Formed from Naturally Occurring Chelating Oxazolinate, Thiazolinate, or Picolinate Units† , 1999 .

[24]  Meir Shinitzky,et al.  Enhancement and inhibition of snake venom phosphodiesterase activity by lysophospholipids , 1998, FEBS letters.

[25]  M. Ávalos,et al.  Glycine‐enhanced inhibition of rat liver nucleotide pyrophosphatase/phosphodiesterase‐I by EDTA: a full account of the reported inhibition by commercial preparations of acidic fibroblast growth factor (FGF‐1) , 1998, FEBS letters.

[26]  L. Pettersson,et al.  Speciation in vanadium bioinorganic systems , 1997 .

[27]  D. D. Mishra,et al.  Oxovanadium binuclear (IV) Schiff base complexes derived from aroyl hydrazones having subnormal magnetic moments , 1997 .

[28]  E. Tiekink,et al.  MONO- AND DINUCLEAR OXOVANADIUM(IV) COMPOUNDS CONTAINING VO(ONS) BASIC CORE : SYNTHESIS, STRUCTURE AND SPECTROSCOPIC PROPERTIES , 1997 .

[29]  C. Orvig,et al.  Oxidation Kinetics of the Potent Insulin Mimetic Agent Bis(maltolato)oxovanadium(IV) (BMOV) in Water and in Methanol. , 1996, Inorganic chemistry.

[30]  C. R. Cornman,et al.  Vanadium(IV) Complexes of an Active-Site Peptide of a Protein Tyrosine Phosphatase , 1995 .

[31]  L. Pettersson,et al.  Speciation in Vanadium Bioinorganic Systems. 2. An NMR, ESR, and Potentiometric Study of the Aqueous H(+)-Vanadate-Maltol System. , 1995, Inorganic chemistry.

[32]  Keiichiro Suzuki,et al.  Apoptotic Cell Death Triggered by Nitric Oxide in Pancreatic β-Cells , 1995, Diabetes.

[33]  Ikezawa Hiroh,et al.  Alkaline phosphodiesterase I release from eucaryotic plasma membranes by phosphatidylinositol-specific phospholipase C--IV. The release from Cacia porcellus organs. , 1994 .

[34]  M. Deutscher Ribonuclease multiplicity, diversity, and complexity. , 1993, The Journal of biological chemistry.

[35]  Xuefeng Yin,et al.  Vanadium as a modulator of cellular regulatory cascades and oncogene expression. , 1993, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[36]  N. Takasu,et al.  Streptozocin- and Alloxan-Induced H2O2 Generation and DNA Fragmentation in Pancreatic Islets: H2O2 as Mediator for DNA Fragmentation , 1991, Diabetes.

[37]  A. Kanthasamy,et al.  Antioxidant effect of vanadate on experimental diabetic rats , 1990, Acta diabetologia latina.

[38]  Arthur I. Vogel,et al.  Vogel's Textbook of Quantitative Chemical Analysis , 1989 .

[39]  M. Deutscher The metabolic role of RNases. , 1988, Trends in biochemical sciences.

[40]  S P Wolff,et al.  Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. , 1987, The Biochemical journal.

[41]  M. Buse,et al.  The Inhibition of Islet Superoxide Dismutase by Diabetogenic Drugs , 1981, Diabetes.

[42]  W. Geary The use of conductivity measurements in organic solvents for the characterisation of coordination compounds , 1971 .

[43]  A. Mclean,et al.  Biochemical mechanisms of liver injury. , 1970, The American journal of medicine.

[44]  H. G. Khorana,et al.  Studies on polynucleotides , 1965 .

[45]  W. E. Razzell,et al.  Studies on polynucleotides. III. Enzymic degradation; substrate specificity and properties of snake venom phosphodiesterase. , 1959, The Journal of biological chemistry.

[46]  D. Rehder Bioinorganic Vanadium Chemistry , 2008 .

[47]  H. Kaneto,et al.  Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells. , 1995, Diabetes.

[48]  H. Ikezawa,et al.  Alkaline phosphodiesterase I release from eucaryotic plasma membranes by phosphatidylinositol-specific phospholipase C--IV. The release from Cacia porcellus organs. , 1994, The International journal of biochemistry.

[49]  W. Linert,et al.  SPECTROSCOPIC, ELECTROCHEMICAL AND QUANTUM MECHANICAL INVESTIGATIONS OF VANADYL(IV)-ACETYLACETONATE IN NON-AQUEOUS SOLUTIONS , 1993 .

[50]  Sprinkle Tj 2',3'-cyclic nucleotide 3'-phosphodiesterase, an oligodendrocyte-Schwann cell and myelin-associated enzyme of the nervous system. , 1989, Critical reviews in neurobiology.